Fibrin monomer complex as a potential thrombosis marker related to venous thromboembolism risk in pregnant women
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · 2023
DOI: 10.1177/00045632231160667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2023. Verfasst von Takuya Iwamoto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Laboratory Medicine, Tottori University Hospital, Yonago, Tottori, Japan. Hauptthemen laut MEDLINE: Venous Thromboembolism, Thrombosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
Pregnancy is a risk factor for venous thromboembolism (VTE) due to increased coagulation factor activity and decreased protein S activity. However, thrombosis markers for predicting VTE in pregnancy remain controversial. This study aimed to investigate the relationship between VTE risk and thrombosis markers in pregnant women and to identify markers related to VTE risk.
Methods
Archived plasma samples from 107 pregnant women were used in this study, and the concentrations of D-dimer, fibrin monomer complex (FMC), plasmin-plasmin inhibitor complex, prothrombin time, activated partial thromboplastin time, and fibrinogen were measured. VTE risk was scored according to the Royal College of Obstetricians and Gynaecologists green-top guidelines and the patients were divided into low- or high-risk groups.
Results
The median (range) of risk score for deep vein thrombosis was 2 (0–8), and we defined the high-risk group included those with a score of ≧3. D-dimer and FMC concentrations were significantly higher in the high-risk group than in the low-risk group (D-dimer 4.5 vs 2.6 μg/mL, p = 0.008; FMC 14.6 vs 3.4 μg/mL, p < 0.001). Although D-dimer concentration significantly increased with gestational age (Spearman’s correlation coefficient [ r s ] = 0.317, p < 0.001), FMC concentration did not ( r s = −0.081, p = 0.409). The area under the receiver operating characteristic curve values of D-dimer, FMC, and both D-dimer and FMC for the high-risk group were 0.656, 0.713, and 0.738, respectively.
Conclusions
FMC may be a thrombosis marker related to VTE risk in pregnancy and is potentially preferable over D-dimer concentrations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Laboratory Medicine, Tottori University Hospital, Yonago, Tottori, Japan.
- Department of Multidisciplinary Internal Medicine, School of Medicine, Tottori University Faculty of Medicine, Yonago, Tottori, Japan.
- Department of Hematology, Tottori University Hospital, Yonago, Tottori, Japan.
ORCID-Profile: Takuya Iwamoto, Yuki Hatayama
Zitieren
APA
Iwamoto, T., Hatayama, Y., Namba, H., Kojima, N., Horie, T., Yamashita, N., Ichikawa, H., Fukuda, T., & Motokura, T. (2023). Fibrin monomer complex as a potential thrombosis marker related to venous thromboembolism risk in pregnant women. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. https://doi.org/10.1177/00045632231160667
Vancouver
Iwamoto T, Hatayama Y, Namba H, Kojima N, Horie T, Yamashita N, et al. Fibrin monomer complex as a potential thrombosis marker related to venous thromboembolism risk in pregnant women. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 2023. doi:10.1177/00045632231160667
BibTeX
@article{Iwamoto2023,
author = {Iwamoto, Takuya and Hatayama, Yuki and Namba, Hiroya and Kojima, Nao and Horie, Takuya and Yamashita, Noriko and Ichikawa, Hitomi and Fukuda, Tetsuya and Motokura, Toru},
title = {Fibrin monomer complex as a potential thrombosis marker related to venous thromboembolism risk in pregnant women},
journal = {Annals of Clinical Biochemistry: International Journal of Laboratory Medicine},
year = {2023},
doi = {10.1177/00045632231160667}
}
EUVIMED